Bone Metastases: Targeted Treatments & Bone Health

Bone is the most common place for breast cancer to spread. When it does, the cancer in the bone is still breast cancer. It is treated with breast cancer drugs, not with bone cancer drugs.

Hearing "it's in your bones" often lands as a death sentence. So it is worth knowing something else. Bone-only metastatic breast cancer is among the more indolent patterns, meaning slow-moving. That is especially true of hormone receptor-positive disease. Many people live with it for years, working, traveling, and managing it as a chronic condition. This is not a promise about your case. But it is a genuine and often unstated fact about this pattern of spread.

Bone metastases may show up on a bone scan, CT, PET-CT, or MRI. Sometimes they are found because of pain, sometimes by chance. Lesions are described as lytic (bone-dissolving, more common in breast cancer), blastic (bone-forming), or mixed. Lytic lesions weaken bone and carry more fracture risk.

Imaging after treatment can be confusing. Healing lytic lesions often become denser. They can look more prominent on a bone scan even when things are improving. This is called a flare response. If a scan report worries you, ask directly whether the change reflects progression or healing.

These are a separate layer of treatment from your cancer therapy. Zoledronic acid and pamidronate are bisphosphonates given intravenously. Denosumab is an antibody given as a subcutaneous injection, meaning under the skin. They reduce fractures, the need for radiation to bone, and spinal cord compression. They also help with cancer-related bone loss.

They do not treat the cancer itself. Your systemic therapy does that. It is common to be on both, and just as common for the difference to go unexplained.

Two practical points. The first is the dosing interval. For many people with breast cancer, zoledronic acid every 12 weeks is as effective as every 4 weeks, which means fewer infusions. It is not a universal switch, though: which agent you get, at what interval, and whether you get one at all depends on your kidney function, your calcium level, how much disease is in the bone and what systemic treatment you are on. The second is dental care. Osteonecrosis of the jaw is uncommon but serious. The risk drops when a dental evaluation happens before starting, and when invasive dental work is completed first. Tell any dentist you are on these drugs. Calcium and vitamin D are usually recommended alongside, and denosumab in particular can drop calcium levels, so blood calcium is checked before and during treatment. Start supplements on your team's instruction rather than on your own, because the right amount depends on your calcium and kidney results.

Radiation is very effective for a painful bone metastasis. It is often given as a single fraction or a short course, and relief typically comes over days to a few weeks. It can be repeated to the same site in many cases. There is no benefit to enduring bone pain that could be treated.

Pain control generally combines radiation, systemic therapy, and analgesics. A palliative care team is often the group with the most expertise here. Involving them early is associated with better quality of life.

Two situations are urgent rather than routine.

Spinal cord compression. Warning signs include new or worsening back or neck pain, especially pain that feels like a band around the chest or abdomen or shoots down a limb; leg weakness or legs giving way; difficulty walking; numbness or pins and needles anywhere; and new problems controlling bladder or bowels, including new constipation or passing little urine. Macmillan Cancer Support puts it directly: this "is an emergency that needs treatment as soon as possible. Do not wait for further symptoms to develop." Contact your oncology team immediately, including at nights and weekends. If you cannot reach anyone quickly, go to an emergency department and say you have breast cancer in the bones and may have spinal cord compression.

Impending or actual fracture. Sudden severe pain in a hip, thigh, or upper arm, pain that worsens sharply with weight-bearing, or inability to bear weight needs prompt evaluation. Some at-risk bones can be stabilized surgically or with radiation before they break.

High calcium. Confusion, unusual thirst, constipation, nausea, and drowsiness can signal hypercalcemia, which is treatable and should be reported promptly.

Ask whether your disease is bone-only or also elsewhere. Ask whether you are on a bone-modifying agent, which one, and how often. Ask whether you have had a dental check. Ask which bones are at fracture risk, and whether any activity limits apply. Ask who to call after hours, and what specifically should prompt that call.

• Macmillan Cancer Support: Metastatic spinal cord compression
• Review of bone-modifying agents in metastatic breast cancer (PMC)
• NCI: Metastatic cancer
• NCI: Radiation therapy to treat cancer
• NCI: Palliative care in cancer fact sheet